nodes	percent_of_prediction	percent_of_DWPC	metapath
Azacitidine—Nucleic Acid Synthesis Inhibitors—Fluorouracil—skin cancer	0.88	1	CiPCiCtD
Azacitidine—DNMT3A—connective tissue—skin cancer	0.00211	0.093	CbGeAlD
Azacitidine—DNMT3A—skin of body—skin cancer	0.00191	0.084	CbGeAlD
Azacitidine—DNMT1—nipple—skin cancer	0.0018	0.0793	CbGeAlD
Azacitidine—CDA—mammalian vulva—skin cancer	0.00164	0.0724	CbGeAlD
Azacitidine—DNMT3A—lymphoid tissue—skin cancer	0.00154	0.068	CbGeAlD
Azacitidine—DNMT3A—female reproductive system—skin cancer	0.00149	0.0656	CbGeAlD
Azacitidine—CDA—lymphoid tissue—skin cancer	0.00146	0.0643	CbGeAlD
Azacitidine—DNMT1—connective tissue—skin cancer	0.00128	0.0563	CbGeAlD
Azacitidine—DNMT3A—head—skin cancer	0.00124	0.0548	CbGeAlD
Azacitidine—DNMT1—epithelium—skin cancer	0.00121	0.0534	CbGeAlD
Azacitidine—DNMT1—skin of body—skin cancer	0.00115	0.0508	CbGeAlD
Azacitidine—DNMT1—mammalian vulva—skin cancer	0.00105	0.0463	CbGeAlD
Azacitidine—DNMT1—lymphoid tissue—skin cancer	0.000933	0.0411	CbGeAlD
Azacitidine—DNMT1—female reproductive system—skin cancer	0.0009	0.0397	CbGeAlD
Azacitidine—DNMT3A—lymph node—skin cancer	0.00087	0.0384	CbGeAlD
Azacitidine—CDA—lymph node—skin cancer	0.000823	0.0363	CbGeAlD
Azacitidine—DNMT1—head—skin cancer	0.000752	0.0331	CbGeAlD
Azacitidine—DNMT1—lymph node—skin cancer	0.000526	0.0232	CbGeAlD
Azacitidine—Body temperature increased—Imiquimod—skin cancer	0.000114	0.00118	CcSEcCtD
Azacitidine—Abdominal pain—Imiquimod—skin cancer	0.000114	0.00118	CcSEcCtD
Azacitidine—Eye disorder—Temozolomide—skin cancer	0.000114	0.00117	CcSEcCtD
Azacitidine—Malaise—Bleomycin—skin cancer	0.000113	0.00117	CcSEcCtD
Azacitidine—Cardiac disorder—Temozolomide—skin cancer	0.000113	0.00117	CcSEcCtD
Azacitidine—Haemoglobin—Fluorouracil—skin cancer	0.000113	0.00116	CcSEcCtD
Azacitidine—Leukopenia—Bleomycin—skin cancer	0.000113	0.00116	CcSEcCtD
Azacitidine—Rhinitis—Fluorouracil—skin cancer	0.000113	0.00116	CcSEcCtD
Azacitidine—Haemorrhage—Fluorouracil—skin cancer	0.000112	0.00116	CcSEcCtD
Azacitidine—Dizziness—Vemurafenib—skin cancer	0.000112	0.00116	CcSEcCtD
Azacitidine—Hypoaesthesia—Fluorouracil—skin cancer	0.000112	0.00115	CcSEcCtD
Azacitidine—Pharyngitis—Fluorouracil—skin cancer	0.000112	0.00115	CcSEcCtD
Azacitidine—Angiopathy—Temozolomide—skin cancer	0.000111	0.00114	CcSEcCtD
Azacitidine—Immune system disorder—Temozolomide—skin cancer	0.00011	0.00114	CcSEcCtD
Azacitidine—Mediastinal disorder—Temozolomide—skin cancer	0.00011	0.00113	CcSEcCtD
Azacitidine—Cough—Bleomycin—skin cancer	0.00011	0.00113	CcSEcCtD
Azacitidine—Chills—Temozolomide—skin cancer	0.000109	0.00113	CcSEcCtD
Azacitidine—Dehydration—Docetaxel—skin cancer	0.000109	0.00112	CcSEcCtD
Azacitidine—Ill-defined disorder—Dactinomycin—skin cancer	0.000109	0.00112	CcSEcCtD
Azacitidine—Anaemia—Dactinomycin—skin cancer	0.000108	0.00112	CcSEcCtD
Azacitidine—Vomiting—Vemurafenib—skin cancer	0.000108	0.00111	CcSEcCtD
Azacitidine—Alopecia—Temozolomide—skin cancer	0.000108	0.00111	CcSEcCtD
Azacitidine—Dry skin—Docetaxel—skin cancer	0.000107	0.00111	CcSEcCtD
Azacitidine—Myalgia—Bleomycin—skin cancer	0.000107	0.0011	CcSEcCtD
Azacitidine—Chest pain—Bleomycin—skin cancer	0.000107	0.0011	CcSEcCtD
Azacitidine—Orthostatic hypotension—Docetaxel—skin cancer	0.000107	0.0011	CcSEcCtD
Azacitidine—Abdominal pain upper—Docetaxel—skin cancer	0.000107	0.0011	CcSEcCtD
Azacitidine—Rash—Vemurafenib—skin cancer	0.000107	0.0011	CcSEcCtD
Azacitidine—Mental disorder—Temozolomide—skin cancer	0.000107	0.0011	CcSEcCtD
Azacitidine—Dermatitis—Vemurafenib—skin cancer	0.000107	0.0011	CcSEcCtD
Azacitidine—Hypersensitivity—Imiquimod—skin cancer	0.000107	0.0011	CcSEcCtD
Azacitidine—Headache—Vemurafenib—skin cancer	0.000106	0.00109	CcSEcCtD
Azacitidine—Erythema—Temozolomide—skin cancer	0.000106	0.00109	CcSEcCtD
Azacitidine—Malnutrition—Temozolomide—skin cancer	0.000106	0.00109	CcSEcCtD
Azacitidine—Discomfort—Bleomycin—skin cancer	0.000106	0.00109	CcSEcCtD
Azacitidine—Malaise—Dactinomycin—skin cancer	0.000106	0.00109	CcSEcCtD
Azacitidine—Cramp muscle—Docetaxel—skin cancer	0.000106	0.00109	CcSEcCtD
Azacitidine—Leukopenia—Dactinomycin—skin cancer	0.000105	0.00108	CcSEcCtD
Azacitidine—Nasopharyngitis—Docetaxel—skin cancer	0.000105	0.00108	CcSEcCtD
Azacitidine—Asthenia—Imiquimod—skin cancer	0.000104	0.00107	CcSEcCtD
Azacitidine—Confusional state—Bleomycin—skin cancer	0.000104	0.00107	CcSEcCtD
Azacitidine—Oedema—Bleomycin—skin cancer	0.000103	0.00106	CcSEcCtD
Azacitidine—Anaphylactic shock—Bleomycin—skin cancer	0.000103	0.00106	CcSEcCtD
Azacitidine—Back pain—Temozolomide—skin cancer	0.000103	0.00106	CcSEcCtD
Azacitidine—Pruritus—Imiquimod—skin cancer	0.000102	0.00105	CcSEcCtD
Azacitidine—Infection—Bleomycin—skin cancer	0.000102	0.00105	CcSEcCtD
Azacitidine—Dysphagia—Docetaxel—skin cancer	0.000101	0.00104	CcSEcCtD
Azacitidine—Nausea—Vemurafenib—skin cancer	0.000101	0.00104	CcSEcCtD
Azacitidine—Thrombocytopenia—Bleomycin—skin cancer	0.000101	0.00104	CcSEcCtD
Azacitidine—Myalgia—Dactinomycin—skin cancer	9.99e-05	0.00103	CcSEcCtD
Azacitidine—Alopecia—Fluorouracil—skin cancer	9.93e-05	0.00102	CcSEcCtD
Azacitidine—Diarrhoea—Imiquimod—skin cancer	9.89e-05	0.00102	CcSEcCtD
Azacitidine—Discomfort—Dactinomycin—skin cancer	9.87e-05	0.00102	CcSEcCtD
Azacitidine—Ill-defined disorder—Temozolomide—skin cancer	9.85e-05	0.00102	CcSEcCtD
Azacitidine—Anaemia—Temozolomide—skin cancer	9.81e-05	0.00101	CcSEcCtD
Azacitidine—Anorexia—Bleomycin—skin cancer	9.79e-05	0.00101	CcSEcCtD
Azacitidine—Erythema—Fluorouracil—skin cancer	9.78e-05	0.00101	CcSEcCtD
Azacitidine—Pancytopenia—Docetaxel—skin cancer	9.62e-05	0.000992	CcSEcCtD
Azacitidine—Hypotension—Bleomycin—skin cancer	9.6e-05	0.000989	CcSEcCtD
Azacitidine—Oedema—Dactinomycin—skin cancer	9.58e-05	0.000987	CcSEcCtD
Azacitidine—Malaise—Temozolomide—skin cancer	9.57e-05	0.000987	CcSEcCtD
Azacitidine—Dizziness—Imiquimod—skin cancer	9.56e-05	0.000986	CcSEcCtD
Azacitidine—Infection—Dactinomycin—skin cancer	9.52e-05	0.000981	CcSEcCtD
Azacitidine—Leukopenia—Temozolomide—skin cancer	9.5e-05	0.00098	CcSEcCtD
Azacitidine—Neutropenia—Docetaxel—skin cancer	9.47e-05	0.000977	CcSEcCtD
Azacitidine—Thrombocytopenia—Dactinomycin—skin cancer	9.38e-05	0.000967	CcSEcCtD
Azacitidine—Musculoskeletal discomfort—Bleomycin—skin cancer	9.36e-05	0.000965	CcSEcCtD
Azacitidine—Cough—Temozolomide—skin cancer	9.26e-05	0.000955	CcSEcCtD
Azacitidine—Convulsion—Temozolomide—skin cancer	9.2e-05	0.000948	CcSEcCtD
Azacitidine—Vomiting—Imiquimod—skin cancer	9.19e-05	0.000948	CcSEcCtD
Azacitidine—Weight decreased—Docetaxel—skin cancer	9.17e-05	0.000945	CcSEcCtD
Azacitidine—Hypertension—Temozolomide—skin cancer	9.17e-05	0.000945	CcSEcCtD
Azacitidine—Dyspnoea—Bleomycin—skin cancer	9.16e-05	0.000944	CcSEcCtD
Azacitidine—Anorexia—Dactinomycin—skin cancer	9.13e-05	0.000941	CcSEcCtD
Azacitidine—Rash—Imiquimod—skin cancer	9.12e-05	0.00094	CcSEcCtD
Azacitidine—Dermatitis—Imiquimod—skin cancer	9.11e-05	0.000939	CcSEcCtD
Azacitidine—Pneumonia—Docetaxel—skin cancer	9.09e-05	0.000937	CcSEcCtD
Azacitidine—Headache—Imiquimod—skin cancer	9.06e-05	0.000934	CcSEcCtD
Azacitidine—Anaemia—Fluorouracil—skin cancer	9.04e-05	0.000932	CcSEcCtD
Azacitidine—Arthralgia—Temozolomide—skin cancer	9.04e-05	0.000932	CcSEcCtD
Azacitidine—Myalgia—Temozolomide—skin cancer	9.04e-05	0.000932	CcSEcCtD
Azacitidine—Infestation NOS—Docetaxel—skin cancer	9.03e-05	0.000931	CcSEcCtD
Azacitidine—Infestation—Docetaxel—skin cancer	9.03e-05	0.000931	CcSEcCtD
Azacitidine—Anxiety—Temozolomide—skin cancer	9.01e-05	0.000928	CcSEcCtD
Azacitidine—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—skin cancer	8.98e-05	0.000925	CcSEcCtD
Azacitidine—Discomfort—Temozolomide—skin cancer	8.93e-05	0.00092	CcSEcCtD
Azacitidine—Decreased appetite—Bleomycin—skin cancer	8.93e-05	0.00092	CcSEcCtD
Azacitidine—Renal failure—Docetaxel—skin cancer	8.88e-05	0.000915	CcSEcCtD
Azacitidine—Stomatitis—Docetaxel—skin cancer	8.81e-05	0.000908	CcSEcCtD
Azacitidine—Pain—Bleomycin—skin cancer	8.78e-05	0.000905	CcSEcCtD
Azacitidine—Leukopenia—Fluorouracil—skin cancer	8.76e-05	0.000903	CcSEcCtD
Azacitidine—Confusional state—Temozolomide—skin cancer	8.74e-05	0.000901	CcSEcCtD
Azacitidine—Musculoskeletal discomfort—Dactinomycin—skin cancer	8.73e-05	0.0009	CcSEcCtD
Azacitidine—Anaphylactic shock—Temozolomide—skin cancer	8.66e-05	0.000893	CcSEcCtD
Azacitidine—Oedema—Temozolomide—skin cancer	8.66e-05	0.000893	CcSEcCtD
Azacitidine—Infection—Temozolomide—skin cancer	8.61e-05	0.000887	CcSEcCtD
Azacitidine—Nausea—Imiquimod—skin cancer	8.59e-05	0.000885	CcSEcCtD
Azacitidine—Hepatobiliary disease—Docetaxel—skin cancer	8.54e-05	0.000881	CcSEcCtD
Azacitidine—Epistaxis—Docetaxel—skin cancer	8.52e-05	0.000878	CcSEcCtD
Azacitidine—Nervous system disorder—Temozolomide—skin cancer	8.5e-05	0.000876	CcSEcCtD
Azacitidine—Thrombocytopenia—Temozolomide—skin cancer	8.48e-05	0.000874	CcSEcCtD
Azacitidine—Convulsion—Fluorouracil—skin cancer	8.47e-05	0.000874	CcSEcCtD
Azacitidine—Feeling abnormal—Bleomycin—skin cancer	8.46e-05	0.000872	CcSEcCtD
Azacitidine—Agranulocytosis—Docetaxel—skin cancer	8.43e-05	0.000869	CcSEcCtD
Azacitidine—Skin disorder—Temozolomide—skin cancer	8.42e-05	0.000868	CcSEcCtD
Azacitidine—Hyperhidrosis—Temozolomide—skin cancer	8.38e-05	0.000863	CcSEcCtD
Azacitidine—Chest pain—Fluorouracil—skin cancer	8.33e-05	0.000858	CcSEcCtD
Azacitidine—Myalgia—Fluorouracil—skin cancer	8.33e-05	0.000858	CcSEcCtD
Azacitidine—Decreased appetite—Dactinomycin—skin cancer	8.33e-05	0.000858	CcSEcCtD
Azacitidine—Fatigue—Dactinomycin—skin cancer	8.26e-05	0.000851	CcSEcCtD
Azacitidine—Anorexia—Temozolomide—skin cancer	8.26e-05	0.000851	CcSEcCtD
Azacitidine—Discomfort—Fluorouracil—skin cancer	8.23e-05	0.000848	CcSEcCtD
Azacitidine—Pain—Dactinomycin—skin cancer	8.19e-05	0.000844	CcSEcCtD
Azacitidine—Urticaria—Bleomycin—skin cancer	8.16e-05	0.000841	CcSEcCtD
Azacitidine—Haemoglobin—Docetaxel—skin cancer	8.15e-05	0.00084	CcSEcCtD
Azacitidine—Rhinitis—Docetaxel—skin cancer	8.13e-05	0.000838	CcSEcCtD
Azacitidine—Body temperature increased—Bleomycin—skin cancer	8.12e-05	0.000837	CcSEcCtD
Azacitidine—Haemorrhage—Docetaxel—skin cancer	8.11e-05	0.000836	CcSEcCtD
Azacitidine—Hypoaesthesia—Docetaxel—skin cancer	8.07e-05	0.000832	CcSEcCtD
Azacitidine—Confusional state—Fluorouracil—skin cancer	8.05e-05	0.00083	CcSEcCtD
Azacitidine—Pharyngitis—Docetaxel—skin cancer	8.05e-05	0.00083	CcSEcCtD
Azacitidine—Urinary tract disorder—Docetaxel—skin cancer	8.01e-05	0.000826	CcSEcCtD
Azacitidine—Oedema peripheral—Docetaxel—skin cancer	7.99e-05	0.000824	CcSEcCtD
Azacitidine—Oedema—Fluorouracil—skin cancer	7.98e-05	0.000823	CcSEcCtD
Azacitidine—Anaphylactic shock—Fluorouracil—skin cancer	7.98e-05	0.000823	CcSEcCtD
Azacitidine—Connective tissue disorder—Docetaxel—skin cancer	7.97e-05	0.000822	CcSEcCtD
Azacitidine—Urethral disorder—Docetaxel—skin cancer	7.95e-05	0.000819	CcSEcCtD
Azacitidine—Infection—Fluorouracil—skin cancer	7.93e-05	0.000818	CcSEcCtD
Azacitidine—Feeling abnormal—Dactinomycin—skin cancer	7.89e-05	0.000814	CcSEcCtD
Azacitidine—Musculoskeletal discomfort—Temozolomide—skin cancer	7.89e-05	0.000814	CcSEcCtD
Azacitidine—Insomnia—Temozolomide—skin cancer	7.84e-05	0.000808	CcSEcCtD
Azacitidine—Gastrointestinal pain—Dactinomycin—skin cancer	7.83e-05	0.000807	CcSEcCtD
Azacitidine—Nervous system disorder—Fluorouracil—skin cancer	7.83e-05	0.000807	CcSEcCtD
Azacitidine—Thrombocytopenia—Fluorouracil—skin cancer	7.82e-05	0.000806	CcSEcCtD
Azacitidine—Tachycardia—Fluorouracil—skin cancer	7.79e-05	0.000803	CcSEcCtD
Azacitidine—Dyspnoea—Temozolomide—skin cancer	7.72e-05	0.000796	CcSEcCtD
Azacitidine—Dyspepsia—Temozolomide—skin cancer	7.63e-05	0.000786	CcSEcCtD
Azacitidine—Anorexia—Fluorouracil—skin cancer	7.61e-05	0.000784	CcSEcCtD
Azacitidine—Eye disorder—Docetaxel—skin cancer	7.58e-05	0.000781	CcSEcCtD
Azacitidine—Abdominal pain—Dactinomycin—skin cancer	7.57e-05	0.000781	CcSEcCtD
Azacitidine—Body temperature increased—Dactinomycin—skin cancer	7.57e-05	0.000781	CcSEcCtD
Azacitidine—Hypersensitivity—Bleomycin—skin cancer	7.57e-05	0.00078	CcSEcCtD
Azacitidine—Decreased appetite—Temozolomide—skin cancer	7.53e-05	0.000776	CcSEcCtD
Azacitidine—Cardiac disorder—Docetaxel—skin cancer	7.53e-05	0.000776	CcSEcCtD
Azacitidine—Gastrointestinal disorder—Temozolomide—skin cancer	7.48e-05	0.000771	CcSEcCtD
Azacitidine—Fatigue—Temozolomide—skin cancer	7.47e-05	0.00077	CcSEcCtD
Azacitidine—Hypotension—Fluorouracil—skin cancer	7.46e-05	0.000769	CcSEcCtD
Azacitidine—Pain—Temozolomide—skin cancer	7.41e-05	0.000764	CcSEcCtD
Azacitidine—Constipation—Temozolomide—skin cancer	7.41e-05	0.000764	CcSEcCtD
Azacitidine—Asthenia—Bleomycin—skin cancer	7.37e-05	0.00076	CcSEcCtD
Azacitidine—Angiopathy—Docetaxel—skin cancer	7.36e-05	0.000758	CcSEcCtD
Azacitidine—Immune system disorder—Docetaxel—skin cancer	7.33e-05	0.000755	CcSEcCtD
Azacitidine—Mediastinal disorder—Docetaxel—skin cancer	7.31e-05	0.000753	CcSEcCtD
Azacitidine—Chills—Docetaxel—skin cancer	7.28e-05	0.00075	CcSEcCtD
Azacitidine—Musculoskeletal discomfort—Fluorouracil—skin cancer	7.27e-05	0.00075	CcSEcCtD
Azacitidine—Pruritus—Bleomycin—skin cancer	7.27e-05	0.000749	CcSEcCtD
Azacitidine—Insomnia—Fluorouracil—skin cancer	7.22e-05	0.000744	CcSEcCtD
Azacitidine—Alopecia—Docetaxel—skin cancer	7.17e-05	0.000739	CcSEcCtD
Azacitidine—Feeling abnormal—Temozolomide—skin cancer	7.14e-05	0.000736	CcSEcCtD
Azacitidine—Dyspnoea—Fluorouracil—skin cancer	7.12e-05	0.000734	CcSEcCtD
Azacitidine—Mental disorder—Docetaxel—skin cancer	7.1e-05	0.000732	CcSEcCtD
Azacitidine—Gastrointestinal pain—Temozolomide—skin cancer	7.08e-05	0.00073	CcSEcCtD
Azacitidine—Erythema—Docetaxel—skin cancer	7.06e-05	0.000728	CcSEcCtD
Azacitidine—Malnutrition—Docetaxel—skin cancer	7.06e-05	0.000728	CcSEcCtD
Azacitidine—Hypersensitivity—Dactinomycin—skin cancer	7.06e-05	0.000728	CcSEcCtD
Azacitidine—Dyspepsia—Fluorouracil—skin cancer	7.03e-05	0.000724	CcSEcCtD
Azacitidine—Decreased appetite—Fluorouracil—skin cancer	6.94e-05	0.000715	CcSEcCtD
Azacitidine—Gastrointestinal disorder—Fluorouracil—skin cancer	6.89e-05	0.00071	CcSEcCtD
Azacitidine—Urticaria—Temozolomide—skin cancer	6.88e-05	0.00071	CcSEcCtD
Azacitidine—Asthenia—Dactinomycin—skin cancer	6.87e-05	0.000708	CcSEcCtD
Azacitidine—Abdominal pain—Temozolomide—skin cancer	6.85e-05	0.000706	CcSEcCtD
Azacitidine—Body temperature increased—Temozolomide—skin cancer	6.85e-05	0.000706	CcSEcCtD
Azacitidine—Back pain—Docetaxel—skin cancer	6.83e-05	0.000704	CcSEcCtD
Azacitidine—Pain—Fluorouracil—skin cancer	6.83e-05	0.000704	CcSEcCtD
Azacitidine—Muscle spasms—Docetaxel—skin cancer	6.79e-05	0.0007	CcSEcCtD
Azacitidine—Feeling abnormal—Fluorouracil—skin cancer	6.58e-05	0.000678	CcSEcCtD
Azacitidine—Diarrhoea—Dactinomycin—skin cancer	6.55e-05	0.000676	CcSEcCtD
Azacitidine—Vomiting—Bleomycin—skin cancer	6.53e-05	0.000673	CcSEcCtD
Azacitidine—Anaemia—Docetaxel—skin cancer	6.52e-05	0.000673	CcSEcCtD
Azacitidine—Rash—Bleomycin—skin cancer	6.48e-05	0.000668	CcSEcCtD
Azacitidine—Dermatitis—Bleomycin—skin cancer	6.47e-05	0.000667	CcSEcCtD
Azacitidine—Hypersensitivity—Temozolomide—skin cancer	6.38e-05	0.000658	CcSEcCtD
Azacitidine—Urticaria—Fluorouracil—skin cancer	6.34e-05	0.000654	CcSEcCtD
Azacitidine—Syncope—Docetaxel—skin cancer	6.33e-05	0.000653	CcSEcCtD
Azacitidine—Leukopenia—Docetaxel—skin cancer	6.32e-05	0.000651	CcSEcCtD
Azacitidine—Body temperature increased—Fluorouracil—skin cancer	6.31e-05	0.000651	CcSEcCtD
Azacitidine—Asthenia—Temozolomide—skin cancer	6.22e-05	0.000641	CcSEcCtD
Azacitidine—Loss of consciousness—Docetaxel—skin cancer	6.2e-05	0.00064	CcSEcCtD
Azacitidine—Cough—Docetaxel—skin cancer	6.16e-05	0.000635	CcSEcCtD
Azacitidine—Pruritus—Temozolomide—skin cancer	6.13e-05	0.000632	CcSEcCtD
Azacitidine—Convulsion—Docetaxel—skin cancer	6.12e-05	0.000631	CcSEcCtD
Azacitidine—Nausea—Bleomycin—skin cancer	6.1e-05	0.000629	CcSEcCtD
Azacitidine—Hypertension—Docetaxel—skin cancer	6.1e-05	0.000628	CcSEcCtD
Azacitidine—Vomiting—Dactinomycin—skin cancer	6.09e-05	0.000628	CcSEcCtD
Azacitidine—Rash—Dactinomycin—skin cancer	6.04e-05	0.000623	CcSEcCtD
Azacitidine—Chest pain—Docetaxel—skin cancer	6.01e-05	0.00062	CcSEcCtD
Azacitidine—Myalgia—Docetaxel—skin cancer	6.01e-05	0.00062	CcSEcCtD
Azacitidine—Arthralgia—Docetaxel—skin cancer	6.01e-05	0.00062	CcSEcCtD
Azacitidine—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—skin cancer	5.97e-05	0.000615	CcSEcCtD
Azacitidine—Diarrhoea—Temozolomide—skin cancer	5.93e-05	0.000611	CcSEcCtD
Azacitidine—Hypersensitivity—Fluorouracil—skin cancer	5.88e-05	0.000606	CcSEcCtD
Azacitidine—Confusional state—Docetaxel—skin cancer	5.81e-05	0.000599	CcSEcCtD
Azacitidine—Oedema—Docetaxel—skin cancer	5.76e-05	0.000594	CcSEcCtD
Azacitidine—Anaphylactic shock—Docetaxel—skin cancer	5.76e-05	0.000594	CcSEcCtD
Azacitidine—Dizziness—Temozolomide—skin cancer	5.73e-05	0.000591	CcSEcCtD
Azacitidine—Infection—Docetaxel—skin cancer	5.72e-05	0.00059	CcSEcCtD
Azacitidine—Nausea—Dactinomycin—skin cancer	5.69e-05	0.000587	CcSEcCtD
Azacitidine—Shock—Docetaxel—skin cancer	5.67e-05	0.000584	CcSEcCtD
Azacitidine—Nervous system disorder—Docetaxel—skin cancer	5.65e-05	0.000582	CcSEcCtD
Azacitidine—Pruritus—Fluorouracil—skin cancer	5.65e-05	0.000582	CcSEcCtD
Azacitidine—Thrombocytopenia—Docetaxel—skin cancer	5.64e-05	0.000582	CcSEcCtD
Azacitidine—Tachycardia—Docetaxel—skin cancer	5.62e-05	0.00058	CcSEcCtD
Azacitidine—Skin disorder—Docetaxel—skin cancer	5.6e-05	0.000577	CcSEcCtD
Azacitidine—Vomiting—Temozolomide—skin cancer	5.51e-05	0.000568	CcSEcCtD
Azacitidine—Anorexia—Docetaxel—skin cancer	5.49e-05	0.000566	CcSEcCtD
Azacitidine—Rash—Temozolomide—skin cancer	5.46e-05	0.000563	CcSEcCtD
Azacitidine—Diarrhoea—Fluorouracil—skin cancer	5.46e-05	0.000563	CcSEcCtD
Azacitidine—Dermatitis—Temozolomide—skin cancer	5.46e-05	0.000563	CcSEcCtD
Azacitidine—Headache—Temozolomide—skin cancer	5.43e-05	0.00056	CcSEcCtD
Azacitidine—Hypotension—Docetaxel—skin cancer	5.38e-05	0.000555	CcSEcCtD
Azacitidine—Dizziness—Fluorouracil—skin cancer	5.28e-05	0.000544	CcSEcCtD
Azacitidine—Musculoskeletal discomfort—Docetaxel—skin cancer	5.25e-05	0.000541	CcSEcCtD
Azacitidine—Insomnia—Docetaxel—skin cancer	5.21e-05	0.000537	CcSEcCtD
Azacitidine—Nausea—Temozolomide—skin cancer	5.15e-05	0.00053	CcSEcCtD
Azacitidine—Dyspnoea—Docetaxel—skin cancer	5.14e-05	0.00053	CcSEcCtD
Azacitidine—Vomiting—Fluorouracil—skin cancer	5.08e-05	0.000523	CcSEcCtD
Azacitidine—Dyspepsia—Docetaxel—skin cancer	5.07e-05	0.000523	CcSEcCtD
Azacitidine—Rash—Fluorouracil—skin cancer	5.03e-05	0.000519	CcSEcCtD
Azacitidine—Dermatitis—Fluorouracil—skin cancer	5.03e-05	0.000518	CcSEcCtD
Azacitidine—Decreased appetite—Docetaxel—skin cancer	5.01e-05	0.000516	CcSEcCtD
Azacitidine—Headache—Fluorouracil—skin cancer	5e-05	0.000516	CcSEcCtD
Azacitidine—Gastrointestinal disorder—Docetaxel—skin cancer	4.97e-05	0.000513	CcSEcCtD
Azacitidine—Fatigue—Docetaxel—skin cancer	4.97e-05	0.000512	CcSEcCtD
Azacitidine—Pain—Docetaxel—skin cancer	4.93e-05	0.000508	CcSEcCtD
Azacitidine—Constipation—Docetaxel—skin cancer	4.93e-05	0.000508	CcSEcCtD
Azacitidine—Feeling abnormal—Docetaxel—skin cancer	4.75e-05	0.000489	CcSEcCtD
Azacitidine—Nausea—Fluorouracil—skin cancer	4.74e-05	0.000489	CcSEcCtD
Azacitidine—Gastrointestinal pain—Docetaxel—skin cancer	4.71e-05	0.000486	CcSEcCtD
Azacitidine—Body temperature increased—Docetaxel—skin cancer	4.55e-05	0.00047	CcSEcCtD
Azacitidine—Abdominal pain—Docetaxel—skin cancer	4.55e-05	0.00047	CcSEcCtD
Azacitidine—Hypersensitivity—Docetaxel—skin cancer	4.24e-05	0.000438	CcSEcCtD
Azacitidine—Asthenia—Docetaxel—skin cancer	4.13e-05	0.000426	CcSEcCtD
Azacitidine—Pruritus—Docetaxel—skin cancer	4.08e-05	0.00042	CcSEcCtD
Azacitidine—Diarrhoea—Docetaxel—skin cancer	3.94e-05	0.000406	CcSEcCtD
Azacitidine—Dizziness—Docetaxel—skin cancer	3.81e-05	0.000393	CcSEcCtD
Azacitidine—Vomiting—Docetaxel—skin cancer	3.66e-05	0.000378	CcSEcCtD
Azacitidine—Rash—Docetaxel—skin cancer	3.63e-05	0.000374	CcSEcCtD
Azacitidine—Dermatitis—Docetaxel—skin cancer	3.63e-05	0.000374	CcSEcCtD
Azacitidine—Headache—Docetaxel—skin cancer	3.61e-05	0.000372	CcSEcCtD
Azacitidine—Nausea—Docetaxel—skin cancer	3.42e-05	0.000353	CcSEcCtD
